Vimta Labs Limited Business Intelligence Report
Vimta Labs Limited Business Intelligence Report
Quality Scores
Latest Quarterly Earnings Summary
No quarterly summary available yet.
AI Summary
Vimta Labs Limited is a premier Indian contract research and testing provider with a diversified footprint across pharmaceuticals, food testing, and environmental monitoring. Over the last five years, the business has transformed from a low-margin testing house to a high-value clinical research and biologics partner, evidenced by EBITDA margins expanding from 17% to a peak of 34% (TTM). The company operates a unique National Reference Food Laboratory and manages FSSAI infrastructure through a 25-year PPP, providing high barriers to entry. While FY24 saw a temporary dip in net profit, recent…
Key Changes in FY2026
Vimta Labs has successfully evolved from a local testing boutique into a diversified contract research organization (CRO) serving a plethora of industries including biopharmaceuticals, electronics, and oil & gas. A pivotal moment in its evolution was the 25-year PPP contract with FSSAI to manage the National Food Laboratory, which significantly moved the company up the value chain in food safety compliance. Over the last decade, the company has diversified into EMI/EMC testing for electronics and environmental monitoring, reducing its reliance on any single sector. Strategic capital expenditure has shifted from basic analytical testing toward high-end preclinical and clinical research services. The recent increase in CWIP from ₹12 Cr in 2023 to ₹75 Cr in 2024 indicates an aggressive push…
Management Commentary
The leadership exhibits high domain expertise and has successfully navigated the transition into specialized testing for electronics and medical devices. Communication through frequent analyst calls and investor presentations is transparent and detailed. Management has been proactive in securing long-term government partnerships, such as the 25-year FSSAI contract, which provides long-term revenue visibility. There is a clear strategic intent to move up the value chain from basic testing to high-end clinical research. Management alignment is supported by a stable promoter holding (approx 36%), though slight dilution via ESOPs is noted.
Financial Highlights
The financial trajectory shows a robust scale-up with revenue growing from INR 181 Cr in FY20 to INR 318 Cr in FY24, maintaining a 3-year CAGR of 15%. Profitability has outpaced revenue growth with a 3-year PAT CAGR of 24%, although FY24 experienced margin compression due to elevated operating costs. Operating Profit Margins (OPM) have shown structural improvement, rising from 17% in FY20 to a terminal TTM rate of 34%. Capital efficiency is strong, with ROCE consistently staying above 18% and peaking at 25% in FY23. The recent uptick in quarterly OPM to 37% suggests a shift toward higher-margin diagnostic and clinical services.
Major Opportunities
- Nearly debt-free balance sheet
- Consistent 30% OPM levels until FY24
- Strategic 25-year PPP contract with FSSAI
Major Risks
- Significant increase in Cash Conversion Cycle (223 days)
- Inventory days spiked to 185 days
- Negative Free Cash Flow in the latest fiscal year
About Vimta Labs Limited's Annual Report & Financial Performance
The latest Vimta Labs Limited annual report (FY2026) is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this Vimta Labs Limited research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
Vimta Labs Limited — Frequently Asked Questions
Explore more Vimta Labs Limited research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.